Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies
about
Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's diseaseSexually dimorphic effects of catechol-O-methyltransferase (COMT) inhibition on dopamine metabolism in multiple brain regionsThe relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007.Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group.
P2860
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies
@ast
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies
@en
type
label
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies
@ast
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies
@en
prefLabel
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies
@ast
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies
@en
P2093
P2860
P1476
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies
@en
P2093
P2860
P356
10.1046/J.1365-2125.2000.00113.X
P407
P577
2000-01-01T00:00:00Z